
Please try another search
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States. Its lead product Plogosertib or plogo, a solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.
Name | Age | Since | Title |
---|---|---|---|
Satis Waran Nair Krishnan | 39 | 2025 | Independent Director |
Inigo Angel Laurduraj | 40 | 2025 | Independent Director |
Sing Ee Wong | 44 | 2025 | Chairman, CEO & President |
Kwang Fock Chong | 45 | 2025 | Independent Director |
Cu Seng Kiu | 35 | 2025 | Executive Director, CFO & Secretary |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review